Vandetanib in patients with inoperable hepatocellular carcinoma: a phase II, randomized, double-blind, placebo-controlled study (Q44063928)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Vandetanib in patients with inoperable hepatocellular carcinoma: a phase II, randomized, double-blind, placebo-controlled study |
scientific article |
Statements
1 reference
Vandetanib in patients with inoperable hepatocellular carcinoma: a phase II, randomized, double-blind, placebo-controlled study (English)
1 reference
1 reference
Chiun Hsu
1 reference
Tsai-Sheng Yang
1 reference
Teh-Ia Huo
1 reference
Ruey-Kuen Hsieh
1 reference
Wei-Shou Hwang
1 reference
Tsai-Yuan Hsieh
1 reference
Wen-Tsung Huang
1 reference
Yee Chao
1 reference
Robin Meng
1 reference
13 January 2012
1 reference
1 reference
56
1 reference
5
1 reference
1097-1103
1 reference